Literature DB >> 2887584

Bilateral abscessed orchiepididymitis associated with sepsis caused by Veillonella parvula and Clostridium perfringens: case report and review of the literature.

P M Arrosagaray, C Salas, M Morales, M Correas, J M Barros, M L Cordon.   

Abstract

Veillonella species is a gram-negative coccus which is part of the anaerobic normal flora in the oral cavity, small intestine, upper respiratory tract, vagina, and urinary tract. The role that this organism plays in infection is not well known, and it is generally associated with other bacteria. We present a case of bilateral abscessed orchiepididymitis associated with septicemia due to Veillonella parvula and, later, to Clostridium perfringens, with the development of severe renal insufficiency and septic shock, which resolved favorably with antibiotic therapy, treatment of shock, and hyperbaric oxygen therapy. In reviewing the literature, we have not found any other case of sepsis due to Veillonella sp. associated with urological disorders.

Entities:  

Mesh:

Year:  1987        PMID: 2887584      PMCID: PMC269280          DOI: 10.1128/jcm.25.8.1579-1580.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Pelvic abscess associated with repeated recovery of veillonella.

Authors:  B T Williams
Journal:  Am J Obstet Gynecol       Date:  1977-10-01       Impact factor: 8.661

Review 2.  Current concepts in the management of carcinoma of the prostate gland.

Authors:  E M Meares
Journal:  Calif Med       Date:  1972-12

3.  Endogenous gas gangrene: a report of three cases.

Authors:  H S Himal; J H Duff
Journal:  Can Med Assoc J       Date:  1967-12-16       Impact factor: 8.262

4.  Anaerobic bacteremia.

Authors:  W R Wilson; W J Martin; C J Wilkowske; J A Washington
Journal:  Mayo Clin Proc       Date:  1972-09       Impact factor: 7.616

5.  Veillonella parvula septicemia and osteomyelitis.

Authors:  K A Borchardt; M Baker; R Gelber
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

6.  Anaerobic infection of the paranasal sinuses.

Authors:  J Frederick; A I Braude
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

7.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

8.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

9.  Osteomyelitis caused by Veillonella.

Authors:  R A Barnhart; M R Weitekamp; R C Aber
Journal:  Am J Med       Date:  1983-05       Impact factor: 4.965

10.  Susceptibility of anaerobic bacteria to ten antimicrobial agents.

Authors:  P C Appelbaum; S A Chatterton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

  10 in total
  4 in total

Review 1.  Veillonella infections in children.

Authors:  I Brook
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

2.  Sepsis caused by Veillonella parvula infection in a 17-year-old patient with X-linked agammaglobulinemia (Bruton's disease).

Authors:  Magdalena Strach; Maciej Siedlar; Danuta Kowalczyk; Marek Zembala; Tomasz Grodzicki
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

3.  Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.

Authors:  Christian Pustelny; Uliana Komor; Vinay Pawar; Anne Lorenz; Agata Bielecka; Annette Moter; Benjamin Gocht; Denitsa Eckweiler; Mathias Müsken; Claudia Grothe; Heinrich Lünsdorf; Siegfried Weiss; Susanne Häussler
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

4.  Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide.

Authors:  Giovanni Matera; Valentina Muto; Maria Vinci; Emilia Zicca; Shahla Abdollahi-Roodsaz; Frank L van de Veerdonk; Bart-Jan Kullberg; Maria Carla Liberto; Jos W M van der Meer; Alfredo Focà; Mihai G Netea; Leo A B Joosten
Journal:  Clin Vaccine Immunol       Date:  2009-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.